EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Driving adoption of new technologies in biopharmaceutical manufacturing

Gene Schaefer iD, John Balchunas, Timothy Charlebois, John Erickson iD, Roger Hart, Sandeep B Kedia iD, Kelvin H Lee iD

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28395 ↗

At a glance

Übersichtsarbeit in Biotechnology and Bioengineering, 2023. Written by Gene Schaefer and 6 co-authors. Institution: National Institute for Innovation in Manufacturing Biopharmaceuticals, Newark, Delaware, USA. Major MEDLINE topics: Drug Industry, Biological Products. Cited 8 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Institute of Standards and Technology.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The challenge of introducing new technologies into established industries is not a problem unique to the biopharmaceutical industry. However, it may be critical to the long‐term competitiveness of individual manufacturers and, more importantly, the ability to deliver therapies to patients. This is especially true for new treatment modalities including cell and gene therapies. We review several barriers to technology adoption which have been identified in various public forums including business, regulatory, technology, and people‐driven concerns. We also summarize suitable enablers addressing one or more of these barriers along with suggestions for developing synergies or connections between innovation in product discovery and manufacturing or across the supplier, discovery, manufacturing, and regulatory arms of the holistic innovation engine.

Subjects

MeSH terms (MEDLINE)

Drug IndustryBiological ProductsHumansTechnology

Author keywords

advanced manufacturingbioprocessinnovationintensified continuous bioprocesstechnology adoption

Substances

Biological Products

Authors and institutions

  • National Institute for Innovation in Manufacturing Biopharmaceuticals, Newark, Delaware, USA.

ORCID profiles: Gene Schaefer, John Erickson, Sandeep B Kedia, Kelvin H Lee

Funding

  • National Institute of Standards and Technology

Cite

APA

Schaefer, G., Balchunas, J., Charlebois, T., Erickson, J., Hart, R., Kedia, S. B., & Lee, K. H. (2023). Driving adoption of new technologies in biopharmaceutical manufacturing. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28395

Vancouver

Schaefer G, Balchunas J, Charlebois T, Erickson J, Hart R, Kedia SB, et al. Driving adoption of new technologies in biopharmaceutical manufacturing. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28395

BibTeX
@article{Schaefer2023,
  author = {Schaefer, Gene and Balchunas, John and Charlebois, Timothy and Erickson, John and Hart, Roger and Kedia, Sandeep B and Lee, Kelvin H},
  title = {Driving adoption of new technologies in biopharmaceutical manufacturing},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28395}
}
Start for free →